This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (44)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Dermatology  • Herpes  • Alert me on articles by topic

Fujie Xu, MD, PhD; Maya R. Sternberg, PhD; Benny J. Kottiri, PhD; Geraldine M. McQuillan, PhD; Francis K. Lee, PhD; Andre J. Nahmias, MD; Stuart M. Berman, MD, ScM; Lauri E. Markowitz, MD

JAMA. 2006;296:964-973.

Context  Herpes simplex virus type 1 (HSV-1) and type 2 are common infections worldwide. Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes and is almost always sexually transmitted. In contrast, HSV-1 is usually transmitted during childhood via nonsexual contacts. Preexisting HSV-1 antibodies can alleviate clinical manifestations of subsequently acquired HSV-2. Furthermore, HSV-1 has become an important cause of genital herpes in some developed countries.

Objective  To examine trends in HSV-1 and HSV-2 seroprevalence in the United States in 1999-2004 compared with 1988-1994.

Design, Settings, and Participants  Cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [NHANES]), were used to compare national seroprevalence estimates from 1999-2004 with those from 1988-1994, and changes in HSV-1 and HSV-2 seroprevalence since 1976-1980 were reviewed. Persons aged 14 to 49 years were included in these analyses.

Main Outcome Measures  Seroprevalence of HSV-1 and HSV-2 antibodies based on results from type-specific immunodot assays; diagnosis of genital herpes.

Results  The overall age-adjusted HSV-2 seroprevalence was 17.0% (95% confidence interval [CI], 15.8%-18.3%) in 1999-2004 and 21.0% (95% CI, 19.1%-23.1%) in 1988-1994, a relative decrease of 19.0% between the 2 surveys (95% CI, –28.6% to –9.5%; P<.001). Decreases in HSV-2 seroprevalence were especially concentrated in persons aged 14 to 19 years between 1988 and 2004. In adolescents aged 17 to 19 years and young adults, the decreases in HSV-2 seroprevalence were significant even after adjusting for changes in sexual behaviors. Among those infected with HSV-2, the percentage who reported having been diagnosed with genital herpes was statistically different (14.3% in 1999-2004 and 9.9% in 1988-1994; P = .02). Seroprevalence of HSV-1 decreased from 62.0% (95% CI, 59.6%-64.6%) in 1988-1994 to 57.7% (95% CI, 55.9%-59.5%) in 1999-2004, a relative decrease of 6.9% between the 2 surveys (95% CI, –11.6% to –2.3%; P = .006). Among persons infected with HSV-1 but not with HSV-2, a higher percentage reported having been diagnosed with genital herpes in 1999-2004 compared with 1988-1994 (1.8% vs 0.4%, respectively; P<.001).

Conclusions  These data show declines in HSV-2 seroprevalence, suggesting that the trajectory of increasing HSV-2 seroprevalence in the United States has been reversed. Seroprevalence of HSV-1 decreased but the incidence of genital herpes caused by HSV-1 may be increasing.

Author Affiliations: Centers for Disease Control and Prevention, Atlanta, Ga (Drs Xu, Sternberg, Kottiri, McQuillan, Berman, and Markowitz); and Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga (Drs Lee and Nahmias).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes complex
Rietmeijer and Low
Sex. Transm. Infect. 2008;84:330-331.
FULL TEXT  

Herpes Simplex Virus Downregulates Secretory Leukocyte Protease Inhibitor: a Novel Immune Evasion Mechanism
Fakioglu et al.
J. Virol. 2008;82:9337-9344.
ABSTRACT | FULL TEXT  

Sexually Transmissible Infections and Prostate Cancer Risk
Huang et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2374-2381.
ABSTRACT | FULL TEXT  

A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine
Brittle et al.
J. Virol. 2008;82:8431-8441.
ABSTRACT | FULL TEXT  

Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E
Hook et al.
J. Virol. 2008;82:6935-6941.
ABSTRACT | FULL TEXT  

Medroxyprogesterone Acetate Inhibits CD8+ T Cell Viral-Specific Effector Function and Induces Herpes Simplex Virus Type 1 Reactivation
Cherpes et al.
J. Immunol. 2008;181:969-975.
ABSTRACT | FULL TEXT  

Clinical Validation of a New Triplex Real-Time Polymerase Chain Reaction Assay for the Detection and Discrimination of Herpes simplex Virus Types 1 and 2
Reil et al.
J. Mol. Diagn. 2008;10:361-367.
ABSTRACT | FULL TEXT  

Geographic Prevalence and Multilevel Determination of Community-level Factors Associated with Herpes Simplex Virus Type 2 Infection in Chennai, India
Jennings et al.
Am J Epidemiol 2008;167:1495-1503.
ABSTRACT | FULL TEXT  

The Treatment of Herpes Simplex Infections: An Evidence-Based Review
Cernik et al.
Arch Intern Med 2008;168:1137-1144.
ABSTRACT | FULL TEXT  

Governing the contagious body: genital herpes, contagion and technologies of the self
Oster and Cheek
Health (London) 2008;12:215-232.
ABSTRACT  

Selective Ablation of Virion Host Shutoff Protein RNase Activity Attenuates Herpes Simplex Virus 2 in Mice
Korom et al.
J. Virol. 2008;82:3642-3653.
ABSTRACT | FULL TEXT  

A new role for Chlamydia trachomatis serology?
Johnson and Horner
Sex. Transm. Infect. 2008;84:79-80.
FULL TEXT  

Reassessing Adolescent Male Sexual and Reproductive Health in the United States: Research and Recommendations
Duberstein Lindberg et al.
American Journal of Men's Health 2008;2:40-56.
ABSTRACT  

Effect of Resiquimod 0.01% Gel on Lesion Healing and Viral Shedding When Applied to Genital Herpes Lesions
Fife et al.
Antimicrob. Agents Chemother. 2008;52:477-482.
ABSTRACT | FULL TEXT  

In search of optimal genital herpes management and standard of care (INSIGHTS): doctors' and patients' perceptions of genital herpes
Romanowski et al.
Sex. Transm. Infect. 2008;84:51-56.
ABSTRACT | FULL TEXT  

Discrimination of Antibody to Herpes B Virus from Antibody to Herpes Simplex Virus Types 1 and 2 in Human and Macaque Sera
Fujima et al.
J. Clin. Microbiol. 2008;46:56-61.
ABSTRACT | FULL TEXT  

Sexually transmitted diseases in the USA: temporal trends
Aral et al.
Sex. Transm. Infect. 2007;83:257-266.
ABSTRACT | FULL TEXT  

Prevalence of HPV Infection Among Females in the United States
Dunne et al.
JAMA 2007;297:813-819.
ABSTRACT | FULL TEXT  

Will Routine Screening Further Reduce HSV Infection Rates?
JWatch Pediatrics 2006;2006:3-3.
FULL TEXT  

Recent Trends in the Seroprevalence of HSV
JWatch Women's Health 2006;2006:4-4.
FULL TEXT  

HSV-1 Genital Herpes on the Rise
JWatch Emergency Med. 2006;2006:4-4.
FULL TEXT  

Evidence of a Decline in the Prevalence of HSV-1 and -2 in the U.S.
Journal Watch Dermatology 2006;2006:3-3.
FULL TEXT  

Prevalence of Herpes Simplex Decreasing in the U.S.
JWatch Infect. Diseases 2006;2006:1-1.
FULL TEXT